Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Comment by roadster8on Oct 22, 2019 3:51am
200 Views
Post# 30253868

RE:RE:RE:RE:RE:Stone Castle Fund

RE:RE:RE:RE:RE:Stone Castle Fund
I am currently not sure if the licensing of the 5 other rooms leads to a revaluation. Theoretically, it should be the case, but RQB can only record revenue, if RQB can really sell everything. There are always reports that speak of market saturation and falling prices, while others speak of bottlenecks. I hope that RQB has concluded really good acceptance agreements. Nonetheless, from my point of view, a countermovement or revaluation would have to be started after licensing. If everything goes well in 2020 (pay debts, generate revenue, bring in profits ?, Europe expansion, Australia deal, further expansions, successful consulting, own products like Lore etc ...), in my view, a complete reassessment should actually take place. With me is also an extremely thick minus in the depot at RQB. Because of the above-mentioned 2020 topics, I still have the hope that we could possibly be in 6 to 12 months at 1$+, the stock then proposes positive news and the way is open to the top. Then the big minus would be forgotten. What is your opinion?
<< Previous
Bullboard Posts
Next >>